Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster ... be $316.85 for a pack of five pens, 15% below the list price ...

After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...

Drugmaker Eli Lilly said Thursday that an experimental ... People who have diabetes can’t make enough insulin, a hormone the pancreas makes to help the body keep blood sugar levels in a certain ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Ottawa, April 25, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global insulin delivery pens market size was exhibited at USD 26,412 million in 2024 and is projected to grow USD 58,086 ...